86
Participants
Start Date
April 30, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Paracetamol
IV Solution, Intravenous, 100 mL (10 mg/mL), 4 times at 6-hour intervals, 24 hours
Placebo
IV Solution, Intravenous, 100 mL (0 mg/mL), 4 times at 6-hour intervals, 24 hours
Local Institution, Madrid
Local Institution, Madrid
Local Institution, Alcorcón
Local Institution, Vizcaya
Local Institution, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY